Qsymia 3.75 mg/23 mg is the initial, low-dose titration capsule of a FDA-approved medication containing phentermine (appetite suppressant) and topiramate (seizure/migraine medication). It is used once daily in the morning to initiate chronic weight management in adults and children (12+) alongside a reduced-calorie diet.
